You can buy or sell Neuronetics and other stocks, options, ETFs, and crypto commission-free!
Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. Read More The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.
52 Week High
52 Week Low
Advertising and Marketing
Yahoo FinanceMay 15
General Electric Co Buys Westinghouse Air Brake Technologies Corp, Neuronetics Inc
- By insider Fairfield, CT, based Investment company General Electric Co buys Westinghouse Air Brake Technologies Corp, Neuronetics Inc during the 3-months ended 2019Q1, according to the most recent filings of the investment company, General Electric Co. As of 2019Q1, General Electric Co owns 5 stocks with a total value of $1.5 billion. These are the details of the buys and sells. New Purchases: WAB, STIM, For the details of GENERAL ELECTRIC CO's stock buys and sells, go to https://www.gurufocus...
Seeking AlphaMay 13
Neuronetics, Inc. CEO Chris Thatcher on Q1 2019 Results - Earnings Call Transcript
Neuronetics, Inc. (NASDAQ:STIM) Q1 2019 Earnings Conference Call May 7, 2019 8:30 AM ET Company Participants Mark Klausner - Investor Relations Chris Thatcher - Chief Executive Officer Peter Donato - Chief Financial Officer Conference Call Participants David Turkaly - JMP Securities Margaret Kaczor - William Blair Jason Mills - Canaccord Genuity Matthew O’Brien - Piper Jaffray Operator Good morning, ladies and gentlemen and welcome to the Q1 2019 Neuronetics Incorporated Earnings Call. At this ti...
Neuronetics to Report First Quarter 2019 Financial and Operating Results and Host Conference Call
MALVERN, Pa., April 23, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it plans to release first quarter 2019 financial and operating results, and certain guidance for the second quarter and full year 2019, prior to market open on Tuesday, May 7, 2019. Chris Thatcher, Chief Executive Offi...
-$0.40 per share
-$0.42 per share